Skip to main content

Some Structural Aspects of Non-covalent DNA Binding Agents

Keywords: Drug-DNA binding, DNA intercalation, Minor Groove binding, Drug Design
Cancer is a group of over 100 diseases known by the prolific increase of cellular mass of the tissues in an unusual manner to cause death of a person.1 In addition, cancerous cells do not adhere to each other and to the inter-cellular matrix. This property of non-adherence enables them to propagate to distant sites in the body and spread the cancer.2
            Modern day drug discovery is fundamentally driven by biology. Biological molecules like DNA & proteins are valuable targets for drug action. DNA is central to several life processes like replication, transcription, etc. DNA produces copies of itself via replication mechanism. On the other hand, DNA transcription results in the synthesis of proteins. Since DNA is an indispensable part of the living system, it can be a valuable target for drug action.3 With the help of DNA binding drugs, one can target vital processes like replication, protein synthesis and cell division which ultimately lead to the treatment of cancer.
Structure of DNA
In order to target DNA, it is essential to understand the structural features of DNA. DNA is a very long thread like polymer composed of a linear array of monomers called nucleotides. The critical feature of DNA is its linear order of the four nucleotides, which are the storehouse of all the encoded information. Each nucleotide is composed of an aromatic base (a purine or pyrimidine ring), deoxyribose sugar and a phosphate group (Fig 1). The hydrogen-bonding surface of the individual bases is inside, at the center of the double helix. The phosphate backbone is outside the double helix.

Figure 1: A nucleotide of DNA showing nitrogenous base, pentose sugar and a phosphate group.
            There are three major forms of DNA commonly found in nature, viz. A, B and Z forms. Main structural features of A, B and Z forms are shown in table 1. B-form DNA is the most common structure type found in humans.
Table 1: Structural Features of A, B and Z DNA double helix

Helix sense
Left handed
Right handed
Mean bp/turn
Inclination of bp to axis
Rise/bp along axis
3.8 Å
2.3 Å
Pitch/turn of helix
45.6 Å
24.6 Å
Mean propeller twist
Glycosyl angle
C: anti, G: syn
Sugar pucker
C: C2'-endo,
G: C2'-exo
20 Å
18 Å
26 Å

Mode of Action of Non-covalent DNA binding drugs
There are two principal modes of drug-DNA binding, viz. Intercalation and minor groove binding. Majority of drug molecules interact with DNA by either of these two methods. Exceptions, however, include drugs which bind in the major groove and to the sugar-phosphate backbone of DNA.
 Intercalative binding
Intercalation can be described as the insertion of drug molecule or a part of it between the base pairs of the DNA double helix (Fig 2).

Figure 2: Drug (magenta) showing intercalation between the base pairs of DNA.
            Bases in each DNA strand are stacked over each other via pi-pi stacking forces. Since the DNA double helix is stable in its structure and configuration, inserting any foreign molecule between the base pairs would disturb its original shape. The incorporation of drug molecule causes unstacking of base pairs leading to the opening of base pairs along with the unwinding of strands of DNA. In general, it is observed that the base pairs next to the intercalation site are not occupied by the drug molecule due to the lack of intercalation cavity in these base pairs.
            The main structural feature for the intercalating drugs is the presence of planar ring systems. Normally, a compound containing two or more six membered fused aromatic rings is capable of intercalation between the DNA base pairs. Stacking forces are essential for a stable drug-DNA intercalation complex. Fused aromatic rings possess enough stacking ability to bind with DNA bases. In addition, the compound may also possess a positively charged atom (like N+) to form cation-pi interactions to facilitate binding. Compounds like Ellipticine4 and Cryptolepine5 are known DNA intercalators.
 Minor Groove binding
Apart from the inward facing base pairs, DNA structure also possesses two groves (major and minor grooves) which run though the entire length of the macromolecule (Fig 3). These grooves differ significantly in their electrostatic potentials, steric effects and hydration characteristics. Structurally, minor groove is narrower and deeper than the major groove.

Figure 3: DNA molecule showing inward facing base pairs and major & minor grooves.
            Major groove possesses greater area and volume than the minor groove. This causes small drug like molecules to slip-off from the major groove side of DNA. The minor groove, however, due to its shape provides enough motifs for small drug like molecules to form hydrogen bonding and van-der-Waal’s contacts with the atoms of DNA to form a comlex.
            Drugs which bind in the minor groove possess a crescent shaped structure which fits according the shape of the minor groove. Typically, minor groove binding molecules have several simple aromatic rings connected by bonds with torsional freedom. This facilitates compounds with the appropriate twist, to fit into the helical curve of the minor groove. Such minor groove binding is accomplished by the displacement of water from the groove and forming van der Waal’s contacts with the helical atoms present in the wall of the minor groove.
            Additional specificity in the binding is derived from contacts between the bound molecule and the edges of the base pairs on the ‘floor’ of the minor groove. Pullman and coworkers6 have shown that the negative electrostatic potential is greater in the AT rich region of the minor groove than GC rich regions and this provides an additional factor for AT specific minor groove binding of cationic species of molecules.
            Examples of minor groove binding drugs are netropsin7, distamycin8,9, Hoechst 3325810,11 and small indole derivatives12 (Fig. 4). DNA minor groove binding ability of small indole derivatives containing a single indole ring and a side chain of variable methyle linker length has recently been reported12,13.

Figure 4: Minor groove binders Netropsin and Distamycin. Netropsin (CPK model) is shown inside the minor groove of DNA.
            It is reported that although, the indole ring is planar, its ability to intercalate between base pairs is less. This is mainly due to less aromaticity in the ring (indole contains a six membered and a five membered ring fused together) and the absence of any positive charge in the molecule. On the other hand, the presence of methylene linker side chain enables it to orient the molecule according to the ‘shape’ of the minor groove making it a minor groove binder.

1. WHO Cancer resources (2006). Retrieved from World Health Organization
2. Kintzios S E, Barberaki M G, Plants That Fight Cancer (CRC Press) 2004.
3. Chaudhauri R P & Hargenrother P J, Curr Opin Biotech, 18 (2007) 497.
4. Canals A, Purciolas M, Aymami J & Coll M, Acta Crystallogr D Biol Crystallogr, 61 (2005) 1009.
5. Lisgarten J N, Coll M, Portugal J, Wright C W & Aymami, J Nat Struct Biol, 9 (2002) 57.
6. Lavery R & Pullman B, Int. J Quant Chem, 20 (2004) 259.
7. Patel D J & Shapiro L, J Biol Chem, 261 (1986) 1230.
8. Fagan P & Wemmer D E, J Am Chem Soc, 114 (1992) 1080.
9. Pelton J G & Wemmer D E, Proc Natl Acad Sci USA, 86 (1989) 5723.
10. Han F, Taulier N & Chalikian T V, Biochemistry 44 (2005) 9785.
11. Searle M S & Embrey K J, Nucleic Acids Res 18 (1990) 3753.
12. Pandya P, Islam M M, Kumar G S, Jayaram B & Kumar S, J Chem Sci 122 (2010) 247.
13. Gupta S P, Pandav K, Pandya P, Kumar G S, Barthwal R & Kumar S, Chem Biol Interface 1 (2011) 297.


Popular posts from this blog

How to test Blood: Confirmatory Tests in Forensic Practice

Preliminary examination of blood stains do not confirm the presence of blood. It merely indicates that the positive stain might be due to blood.
In order to confirm the identity of blood, there are certain crystal and spectroscopic tests that are regularly employed in the forensic science laboratories.

1. Takayama Test:

Reagent Preparation:

Standard Glucose Solution (100g/100ml) 3 ml
10% Sodium hydroxide (NaOH) 3 ml
Pyridine 3 ml
Distilled Water 7 ml
Reagents should be made fresh daily.

1. Place material to be tested on a microscopic slide and cover with a cover slip.
2. Add a drop of Takayama Reagentand allow to flow under the cover slip.
3. Warm slide gently at 65oC for 10-20 seconds
4. Allow to cool and observe under microscope at 100X magnification.
The appearance of pink needle shaped crystals of pyridine hemochromogen (Pyridine ferroprotoprophyrin) is positive reaction for heme.

2. Teichmann’s Test:

Reagent Preparation:
Potassium Chloride or 0.1 g
Potassium Bro…

How to Sketch a Molecule from Scratch: Part-1

It is often necessary in various scientific disciplines to prepare sketches of molecules for project reports, research papers and teaching assignments, etc. Drawing a sketch also helps in developing the concepts in science, for example, the bonding patter in organic molecules, their valencies, etc. Educators and researchers regularly use sketches in their daily work. With the development of computing computer based sketching has become more  common and more and more people are using computers for everything for drug design, manufacturing and publications of results. Several tools are available for sketching. Here, we will see how small molecules can be drawn using an exciting and free software ‘ACDChem Sketch’ from ACD Labs. Lets begin by drawing a simple molecule ‘Indole’. The pictures below are self explaining.

You can build a larger molecule by adding side chains at the desired positions on the main Indole ring. The method is shown below.

Apart from building simpler molecule like indole…


DATED: 29.07.2016

For Detailed Information Please Visit the following links: